reference bacterial strains s aureus atcc 29213  (ATCC)

Journal: Molecules

Article Title: Design, Synthesis, and Anticancer and Antibacterial Activities of Quinoline-5-Sulfonamides

doi: 10.3390/molecules29174044

Figure Lengend Snippet: Lowest MIC values with at least 70% inhibition of S. aureus ATCC 29213 respiratory activity.

Article Snippet: Biological screening performed on three cancer cell lines C-32, MDA-MB-231, and A549, reference bacterial strains S. aureus ATCC 29213 and E. faecalis ATCC 29212, and clinical isolates of MRSA and VRE demonstrated the inactivity of 8-methoxy derivatives 6a – d as well as 1,2,3-triazole derivatives 7a – h . In contrast, the acetylenic derivatives of 8-hydroxyquinoline-5-sulfonamide 3a – f were shown to be biologically active.

Techniques: Inhibition, Activity Assay

Journal: Lipids

Article Title: Antibacterial activity of hexadecynoic acid isomers towards clinical isolates of multidrug-resistant Staphylococcus aureus

doi: 10.1002/lipd.12213

Figure Lengend Snippet: Antibacterial activity of HDA analogs against multidrug-resistant bacteria. a

Article Snippet: It was also observed that 3-HDA is 32- to 255-fold less active than 1 in all S. aureus strains displayed in . table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Compounds MIC/GI 50 ± SEM, μg/mL Bacterial Strains S. aureus ATCC 29213 b CIMRSA XI CIMRSA XII CIMRSA XIII CIMRSA XIV CIMRSA XV CIMRSA XVI E. coli ATCC 25922 b 1 7.8/ 3.3 ± 0.3 0.49/0.30 ± 0.03 0.49/0.25 ± 0.03 0.24/0.16 ± 0.02 0.49/0.34 ± 0.03 0.49/0.27 ± 0.01 0.49/0.30 ± 0.03 >1,00 3-HDA ( 7a ) 250/107.8± 5.4 62.5/43.4 ± 1.1 125/89.2 ± 0.9 500/200.6 ± 1.1 62.5/35.1 ± 3.5 15.6/8.7 ± 0.9 62.5/37.9 ± 3.8 >1,000 Open in a separate window a Experiments were performed in triplicate (N =3).

Techniques: Activity Assay